Costs saved and avoided from pharmacist interventions to address drug-related problems identified from outpatient clinics in Jordan

TL;DR

This study shows that pharmacist interventions in Jordan's outpatient clinics helped save and avoid significant healthcare costs by addressing drug-related problems.

Contribution

The study quantifies the economic impact of pharmacist interventions in resolving drug-related problems in Jordan's healthcare system.

Findings

The most frequent drug-related problem was 'Miscellaneous,' addressed by diagnostic interventions in 95.07% of cases.

Total monthly cost avoided was JOD 1,418,720, and total cost saved over the study period was JOD 17,250.204.

Prescription medication count and specific drug classes increased the likelihood of drug-related problems.

Abstract

The pharmacist plays an essential role in identifying and managing drug-related problems. The aim of this research was to assess the costs avoided by clinical pharmacist interventions to resolve drug-related problems.

Clinical pharmacists identified drug-related problems and interventions to address them in consecutive outpatients visiting internal medicine clinics at major teaching and public hospitals in Jordan from September 2012 to December 2013. The costs avoided by each intervention to address drug-related problems were collected from the literature. The collected data were used to calculate the overall cost saved and avoided by the interventions implemented to address the identified drug-related problems, adopting a Jordanian healthcare system perspective.

A total of 2747 patients were enrolled in the study. Diagnostic interventions, such as the need for additional diagnostic testing, were employed in 95.07% of the 13935 intervention to address the drug-related problem “Miscellaneous” which was the most frequent drug-related problems. Other common drug-related problems categories included inappropriate knowledge (n = 6972), inappropriate adherence (4447), efficacy-related drug-related problem (3395) and unnecessary drug therapy (1082). The total cost avoided over the research period was JOD 1418720 per month and total cost saved over the study period was JOD 17250.204. Drug-related problems were associated the number of prescription medications (odds ratio = 1.105; 95% confidence interval = 1.069–1.142), prescribed gastrointestinal drugs (3.485; 2.86–4.247), prescribed antimicrobials (3.326; 1.084–10.205), and prescribed musculoskeletal drugs (1.385; 1.011–1.852).

The study revealed that pharmacists have provided cognitive input to rationalize and optimize the medication use and prevent errors, that led to the reported projected avoided and saved expenditures via various interventions to address drug-related problems. This highlights the added economic impact to the clinical impact of drug-related problems on patients and the healthcare system. The high prevalence and cost of drug-related problems offer strong rationale for pharmacists to provide more vigilant intervention to improve patient outcomes while maintaining cost effectiveness.

Figures